Velagliflozin (Senvelgo) side effects in dogs

72 reports sent to the FDA between 2023 and 2026 involve Velagliflozin in dogs. The most reported problems were overdose, diarrhea, vomiting. 1.4% were marked serious.

72Reports

1.4%Marked serious

13%Only medicine involved

82%Recovered

0.0%Died or euthanised

About this medicine

Velagliflozin treats diabetes in cats (oral, an SGLT2 inhibitor).

Products with this ingredient include Senvelgo. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Most reported side effects

Overdose

31 43%

Diarrhea

20 28%

Vomiting

18 25%

Drooling

10 14%

Wound

5 6.9%

Itching

4 5.6%

Skin rash or irritation

3 4.2%

Skin scab

3 4.2%

Dermal cyst(s)

3 4.2%

Blood in faeces

2 2.8%

Ocular discharge

2 2.8%

Abrasion

2 2.8%

Reddening of the skin

2 2.8%

Skin lump

2 2.8%

Blood loss

1 1.4%

Share = percentage of this medicine's reports that mention the problem. One report can list several problems.

How soon problems started

Same day

3 4.3%

1–2 days

4 5.8%

3–7 days

4 5.8%

1–4 weeks

30 43%

Over a month

28 41%

Time from the first dose to the first sign, where both dates were reported (69 reports).

How the animals did

Recovered

59 82%

Not known

13 18%

Breeds named most often

Popular breeds appear more often because there are more of them.

Beagle 68 reports
Alaskan Malamute 1 reports
Cocker American Spaniel 1 reports

Other hormone or endocrine medicines for dogs

Trilostane (Vetoryl)11,924 reports · 46% serious Insulin7,358 reports · 53% serious Phenylpropanolamine (Proin)4,138 reports · 38% serious Levothyroxine3,012 reports · 44% serious